Why the study?
Does pharmacotherapy and psychotherapy improve cognitive dysfunction and functional disability in patients with major depressive disorder?
Population
Patients with Major Depressive Disorder (MDD)
Design
Review
Authors
Loading...
Standard MDD therapies may not resolve persistent cognitive dysfunction; leaves open targeted treatment trials.
Does pharmacotherapy and psychotherapy improve cognitive dysfunction and functional disability in patients with major depressive disorder?
Cognitive dysfunction is a core feature of MDD that persists even during symptom remission and may be a primary mediator of functional impairment, highlighting the need for targeted treatments.
Lam et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: